SD Biosensor to acquire Relab for $50m.

Synopsis

SD Biosensor, a manufacturer of COVID-19 test kits, agreed to acquire Relab, an Italian medical device distributor, for $50m.

Principals

RELAB

Sd Biosensor

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

ernst & young

HQ - London

financial advisors

bidder

3797

Deals

£ 959.82 B

Total Value

deloitte

HQ - London

financial advisors

target

1573

Deals

£ 427.74 B

Total Value